ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing.

Kanut Laoharawee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.